← All trials
NCT05909358
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 31, 2023
- Primary completion
- Sep 30, 2027
- Completion date
- Sep 30, 2027
- First posted
- Jun 18, 2023
- Last posted
- Jun 18, 2023
- Enrollment
- 2121
- Arms / groups
- 4 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Makerere UniversityLead sponsor
- EpicentreCollaborator
- Makerere UniversityReponsible party - principal investigator
- Makerere UniversityCollaborator
- Government of UgandaCollaborator
- Medical Research Council-UVRI Uganda Research Unit on AIDSCollaborator
- Makerere UniversitySponsor investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.